323 related articles for article (PubMed ID: 23821414)
1. Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial.
Ghaleiha A; Mohammadi E; Mohammadi MR; Farokhnia M; Modabbernia A; Yekehtaz H; Ashrafi M; Hassanzadeh E; Akhondzadeh S
Paediatr Drugs; 2013 Dec; 15(6):505-14. PubMed ID: 23821414
[TBL] [Abstract][Full Text] [Related]
2. l-Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
Hajizadeh-Zaker R; Ghajar A; Mesgarpour B; Afarideh M; Mohammadi MR; Akhondzadeh S
J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):74-81. PubMed ID: 29027815
[TBL] [Abstract][Full Text] [Related]
3. Minocycline as Adjunctive Treatment to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial.
Ghaleiha A; Alikhani R; Kazemi MR; Mohammadi MR; Mohammadinejad P; Zeinoddini A; Hamedi M; Shahriari M; Keshavarzi Z; Akhondzadeh S
J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):784-791. PubMed ID: 27128958
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.
Asadabadi M; Mohammadi MR; Ghanizadeh A; Modabbernia A; Ashrafi M; Hassanzadeh E; Forghani S; Akhondzadeh S
Psychopharmacology (Berl); 2013 Jan; 225(1):51-9. PubMed ID: 22782459
[TBL] [Abstract][Full Text] [Related]
5. Risperidone Combination Therapy With Propentofylline for Treatment of Irritability in Autism Spectrum Disorders: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Behmanesh H; Moghaddam HS; Mohammadi MR; Akhondzadeh S
Clin Neuropharmacol; 2019; 42(6):189-196. PubMed ID: 31725473
[TBL] [Abstract][Full Text] [Related]
6. N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and safety.
Nikoo M; Radnia H; Farokhnia M; Mohammadi MR; Akhondzadeh S
Clin Neuropharmacol; 2015; 38(1):11-7. PubMed ID: 25580916
[TBL] [Abstract][Full Text] [Related]
7. A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism.
Ghaleiha A; Rasa SM; Nikoo M; Farokhnia M; Mohammadi MR; Akhondzadeh S
Psychiatry Res; 2015 Sep; 229(1-2):181-7. PubMed ID: 26208985
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.
Rezaei V; Mohammadi MR; Ghanizadeh A; Sahraian A; Tabrizi M; Rezazadeh SA; Akhondzadeh S
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1269-72. PubMed ID: 20637249
[TBL] [Abstract][Full Text] [Related]
9. Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial.
Ghaleiha A; Ghyasvand M; Mohammadi MR; Farokhnia M; Yadegari N; Tabrizi M; Hajiaghaee R; Yekehtaz H; Akhondzadeh S
J Psychopharmacol; 2014 Jul; 28(7):677-85. PubMed ID: 24132248
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol as adjunctive therapy in treatment of irritability in children with autism: A double-blind and placebo-controlled randomized trial.
Hendouei F; Sanjari Moghaddam H; Mohammadi MR; Taslimi N; Rezaei F; Akhondzadeh S
J Clin Pharm Ther; 2020 Apr; 45(2):324-334. PubMed ID: 31714621
[TBL] [Abstract][Full Text] [Related]
11. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.
Aman M; Rettiganti M; Nagaraja HN; Hollway JA; McCracken J; McDougle CJ; Tierney E; Scahill L; Arnold LE; Hellings J; Posey DJ; Swiezy NB; Ghuman J; Grados M; Shah B; Vitiello B
J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):482-93. PubMed ID: 26262903
[TBL] [Abstract][Full Text] [Related]
12. A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders.
Ghanizadeh A; Moghimi-Sarani E
BMC Psychiatry; 2013 Jul; 13():196. PubMed ID: 23886027
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin as an Adjunctive Therapy to Risperidone in Treatment of Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Moazen-Zadeh E; Shirzad F; Karkhaneh-Yousefi MA; Khezri R; Mohammadi MR; Akhondzadeh S
J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):82-89. PubMed ID: 28719227
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia.
Farokhnia M; Sabzabadi M; Pourmahmoud H; Khodaie-Ardakani MR; Hosseini SM; Yekehtaz H; Tabrizi M; Rezaei F; Salehi B; Akhondzadeh S
Psychopharmacology (Berl); 2014 Feb; 231(3):533-42. PubMed ID: 24013610
[TBL] [Abstract][Full Text] [Related]
15. Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism.
Akhondzadeh S; Fallah J; Mohammadi MR; Imani R; Mohammadi M; Salehi B; Ghanizadeh A; Raznahan M; Mohebbi-Rasa S; Rezazadeh SA; Forghani S
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):32-6. PubMed ID: 19772883
[TBL] [Abstract][Full Text] [Related]
16. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
[TBL] [Abstract][Full Text] [Related]
17. Risperidone in children with autism and serious behavioral problems.
McCracken JT; McGough J; Shah B; Cronin P; Hong D; Aman MG; Arnold LE; Lindsay R; Nash P; Hollway J; McDougle CJ; Posey D; Swiezy N; Kohn A; Scahill L; Martin A; Koenig K; Volkmar F; Carroll D; Lancor A; Tierney E; Ghuman J; Gonzalez NM; Grados M; Vitiello B; Ritz L; Davies M; Robinson J; McMahon D;
N Engl J Med; 2002 Aug; 347(5):314-21. PubMed ID: 12151468
[TBL] [Abstract][Full Text] [Related]
18. A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder.
Akhondzadeh S; Tajdar H; Mohammadi MR; Mohammadi M; Nouroozinejad GH; Shabstari OL; Ghelichnia HA
Child Psychiatry Hum Dev; 2008 Sep; 39(3):237-45. PubMed ID: 17929164
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, placebo-controlled trial of risperidone plus amantadine in children with autism: a 10-week randomized study.
Mohammadi MR; Yadegari N; Hassanzadeh E; Farokhnia M; Yekehtaz H; Mirshafiee O; Akhondzadeh S
Clin Neuropharmacol; 2013; 36(6):179-84. PubMed ID: 24201232
[TBL] [Abstract][Full Text] [Related]
20. Initial severity and efficacy of risperidone in autism: Results from the RUPP trial.
Levine SZ; Kodesh A; Goldberg Y; Reichenberg A; Furukawa TA; Kolevzon A; Leucht S
Eur Psychiatry; 2016 Feb; 32():16-20. PubMed ID: 26802979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
